Related Experiment Video
Updated: Apr 30, 2026

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis
Published on: January 31, 2025
Sonic hedgehog pathway contributes to gastric cancer cell growth and proliferation
Jianhua Wan1, Ji Zhou2, Hailong Zhao1
1State Key Laboratory of Silkworm Genome Biology, Southwest University , Chongqing, China .
Abstract:
The Sonic Hedgehog (Shh) signaling pathway is commonly activated in gastrointestinal cancer. However, our understanding of the Shh pathway in gastric cancer remains limited. Here we examined the effects of cyclopamine, a specific inhibitor of the Shh signaling pathway, on cell growth and proliferation in gastric primary cancer cells GAM-016 and the MKN-45 cell line. The results showed that the Shh signaling molecules SHH, PTCH, SMO, GLI1, and GLI2 were intact and activated in both types of cells. Furthermore, we observed that cyclopamine inhibited gastric cancer cell proliferation through cell cycle arrest and apoptosis. An in vivo study using NOD/SCID mouse xenografts demonstrated that cyclopamine significantly prevented tumor growth and development. Our study indicated that Shh signaling pathway could promote gastric cancer cell proliferation and tumor development, and blocking this pathway may be a potential strategy in gastric cancer treatment.
Insights
Blocking the Sonic Hedgehog (Shh) pathway with cyclopamine inhibits gastric cancer cell growth and tumor development. This study suggests targeting the Shh pathway as a potential gastric cancer treatment strategy.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Signaling Pathways
Background:
- The Sonic Hedgehog (Shh) signaling pathway is frequently activated in gastrointestinal cancers.
- Limited understanding exists regarding the Shh pathway's specific role in gastric cancer progression.
Purpose of the Study:
- To investigate the effects of cyclopamine, a Shh pathway inhibitor, on gastric cancer cell growth and proliferation.
- To evaluate the therapeutic potential of inhibiting the Shh pathway in gastric cancer models.
Main Methods:
- Utilized gastric cancer cell lines (GAM-016, MKN-45) and primary cells.
- Administered cyclopamine to assess its impact on cell cycle and apoptosis.
- Conducted in vivo studies using NOD/SCID mouse xenografts to evaluate tumor growth inhibition.
Main Results:
- Shh pathway molecules (SHH, PTCH, SMO, GLI1, GLI2) were found to be activated in gastric cancer cells.
- Cyclopamine treatment resulted in cell cycle arrest and apoptosis, inhibiting cancer cell proliferation.
- In vivo experiments showed significant suppression of tumor growth and development with cyclopamine.
Conclusions:
- The Shh signaling pathway promotes gastric cancer cell proliferation and tumor development.
- Inhibiting the Shh pathway with cyclopamine demonstrates therapeutic potential for gastric cancer treatment.
Related Concept Videos
Hedgehog Signaling Pathway
Hedgehog Signaling Pathway
Gastritis II: Pathophysiology
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...

